Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Cristi R, King"'
Autor:
Kathryn J. Lindley, Nita A. Limdi, Larisa H. Cavallari, Minoli A. Perera, Petra Lenzini, Julie A. Johnson, Alan H. B. Wu, Paul M Ridker, Cristi R. King, Charles S. Eby, Shitalben Patel, Shimoli V. Shah, T. Mark Beasley, Juan Li, Brian F. Gage
Publikováno v:
Clinical Pharmacology & Therapeutics. 111:950-955
Pharmacogenetic dosing improves the accuracy of warfarin dosing, but current pharmacogenetic dosing algorithms are less accurate in populations of African ancestry. The cytochrome P450 2C9*5 (CYP2C9*5) allele is found almost exclusively in population
Autor:
Michael M. Binkley, Micah Iticovici, Cristi R. King, William H. Goo, Matthew A. Ciorba, Misty Good, Usama Ismail, Kelli L. VanDussen, Vered Gazit, Deborah C. Rubin, Elzbieta A. Swietlicki, Mahama A. Traore, Cliff J. Luke, J. Mark Meacham, Thaddeus S. Stappenbeck, Steven C. George, David M. Alvarado, Brad W. Warner, Adam Bajinting, Wyatt E. Lanik, Jocelyn Ou, Kristen M. Seiler, Jun Guo
Publikováno v:
Scientific Reports
Scientific Reports, Vol 10, Iss 1, Pp 1-14 (2020)
Scientific Reports, Vol 10, Iss 1, Pp 1-14 (2020)
The development and physiologic role of small intestine (SI) vasculature is poorly studied. This is partly due to a lack of targetable, organ-specific markers for in vivo studies of two critical tissue components: endothelium and stroma. This challen
Autor:
Wesley Hollomon, Gina Hyun, Noor Al-Hammadi, Rhonda Porche-Sorbet, Amir K. Jaffer, Juan Li, Charles S. Eby, Victor G. Davila-Roman, Anna M. Thompson, Brian F. Gage, Lynnae Napoli, Brandi De Vore Whipple, J. Philip Miller, Jeffrey L. Anderson, Robert L. Barrack, Robert C. Pendleton, Ryan M. Nunley, Gerard Moskowitz, Kerri Merritt, Tomás Rodriguez, Gwendolyn A. McMillin, Anne R. Bass, H. Lin, Scott C. Woller, Scott M. Stevens, Cristi R. King
Importance The optimal international normalized ratio (INR) to prevent venous thromboembolism (VTE) in warfarin-treated patients with recent arthroplasty is unknown. Objective To determine the safety and efficacy of a target INR of 1.8 vs 2.5 for VTE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f096776e47f2c7e97301a6b53f933338
https://europepmc.org/articles/PMC6724181/
https://europepmc.org/articles/PMC6724181/
Autor:
Cristi R. King, Karen L. Christman, Nick Joseph Merna, Kelsey Michiko Fung, Steven C. George, Kirk C. Hansen, Jean J. Wang
Publikováno v:
Tissue Engineering Part A. 21:2195-2205
Extracellular matrix (ECM) derived from whole organ decellularization has been successfully used in a variety of tissue engineering applications. ECM contains a complex mixture of functional and structural molecules that are ideally suited for the ti
Autor:
Jane Y Revollo, Robert H. Gilman, Derek J. Van Booven, Cristi R. King, Sharon Marsh, Howard L. McLeod
Publikováno v:
Pharmacogenomics. 16:441-448
Background: Clinically relevant polymorphisms often demonstrate population-specific allele frequencies. Central and South America remain largely uncategorized in the context of pharmacogenomics. Materials & methods: We assessed 15 polymorphisms from
Autor:
Ramesh K. Ramanathan, Sharon Marsh, Roscoe F. Morton, Stephen K. Williamson, Erin M. Green, Daniel J. Sargent, Stephen N. Thibodeau, Charles S. Fuchs, Richard M. Goldberg, B. Findlay, Axel Grothey, Howard L. McLeod, Cristi R. King
Publikováno v:
Journal of Clinical Oncology. 28:3227-3233
Purpose With three available chemotherapy drugs for advanced colorectal cancer (CRC), response rate (RR) and survival outcomes have improved with associated morbidity, accentuating the need for tools to select optimal individualized treatment. Pharma
Autor:
Daniel C. Koboldt, Charles S. Eby, Paul E. Milligan, Howard L. McLeod, R D Miller, Gloria R. Grice, P A Lenzini, M Crankshaw, Paul M. Ridker, Brian F. Gage, Rhonda Porche-Sorbet, Larisa H. Cavallari, Shitalben R. Patel, Elena Deych, Cristi R. King, Deepak Voora
Publikováno v:
Clinical Pharmacology & Therapeutics. 87:445-451
Warfarin demonstrates a wide interindividual variability in response that is mediated partly by variants in cytochrome P450 2C9 (CYP2C9) and vitamin K 2,3-epoxide reductase complex subunit 1 (VKORC1). It is not known whether variants in calumenin (CA
Autor:
Brian F. Gage, Elena Deych, Charles S. Eby, Paul M. Ridker, Rhonda Porche-Sorbet, Paul E. Milligan, Gloria R. Grice, Petra A. Lenzini, Cristi R. King
Publikováno v:
Thrombosis and Haemostasis. 104:750-754
SummaryVia generation of vitamin K-dependent proteins, gamma-glutamyl carboxylase (GGCX) plays a critical role in the vitamin K cycle. Single nucleotide polymorphisms (SNPs) in GGCX, therefore, may affect dosing of the vitamin K antagonist, warfarin.
Autor:
Cristi R. King, Rhonda Porche-Sorbet, Paul M. Ridker, Brian F. Gage, Yannick Renaud, Michael S. Phillips, Charles S. Eby
Publikováno v:
American Journal of Clinical Pathology. 129:876-883
Initiation of warfarin therapy is associated with bleeding owing to its narrow therapeutic window and unpredictable therapeutic dose. Pharmacogenetic-based dosing algorithms can improve accuracy of initial warfarin dosing but require rapid genotyping
Publikováno v:
Journal of Clinical Oncology. 25:4528-4535
Purpose Standard therapy for advanced ovarian cancer consists of a platinum agent in combination with a taxane, which has a 5-year survival rate of approximately 45%. The large individual variability for ovarian cancer patients in both outcome and to